Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,958 total articles

Richtech Robotics to Showcase Dual-Armed AI-Powered ADAM and DUST-E S Autonomous Cleaning Robots at HITEC 2026

Richtech Robotics to Showcase Dual-Armed AI-Powered ADAM and DUST-E S Autonomous Cleaning Robots at HITEC 2026

Richtech Robotics announces its participation at HITEC 2026 to showcase its innovative AI-driven dual-armed beverage-serving robot ADAM and autonomous cleaning robot DUST-E S. These robotic solutions aim to enhance operational efficiency, improve guest experiences, and address labor shortages in the hospitality industry. The live demonstrations wil…

Factorial Files Super 8-K Containing Q1 2026 Financial Results

Factorial Files Super 8-K Containing Q1 2026 Financial Results

Factorial Energy Inc., a U.S. solid-state battery innovator, filed a Super 8-K report containing its Q1 2026 financial statements following its merger with Cartesian Growth Corporation III. The company plans to release Q2 2026 results around August 13, 2026, highlighting ongoing advancements in its solid-state battery technology and strategic partn…

Capital Clean Energy Carriers Corp. Forms Joint Venture with CMA CGM S.A. to Build and Operate an LNG Bunkering Vessel

Capital Clean Energy Carriers Corp. Forms Joint Venture with CMA CGM S.A. to Build and Operate an LNG Bunkering Vessel

Capital Clean Energy Carriers Corp. has formed a 50/50 joint venture with CMA CGM S.A. to construct, charter, and operate a 20,000 cbm dual-fuel LNG bunkering vessel to be delivered in Q3 2028. This marks CCEC's entry into the LNG bunkering segment, creating a new long-term contracted revenue stream via a 12-year time charter with a CMA CGM and Tot…

Shell announces pause in share buyback programme

Shell announces pause in share buyback programme

Shell plc announced a suspension of its $3 billion share buyback program starting June 12, 2026, through July 14, 2026, due to securities law requirements related to the publication of ARC Resources Ltd.'s shareholder circular and upcoming shareholder meeting. The suspension is temporary, and any deferred buybacks may be included in future programs…

Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting

Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting

Disc Medicine shared positive clinical data from its RALLY-MF and HELIOS trials at the 2026 European Hematology Association meeting, showing meaningful anemia responses for DISC-0974 in myelofibrosis patients and sustained benefits of bitopertin in erythropoietic protoporphyria patients. The company also previewed upcoming data for DISC-3405 in pol…

Quantum Cyber Terminates At-the-Market Facility, Citing Strengthened Financial Position and No Immediate Capital Needs

Quantum Cyber Terminates At-the-Market Facility, Citing Strengthened Financial Position and No Immediate Capital Needs

Quantum Cyber N.V. has terminated its at-the-market (ATM) issuance sales agreement with Maxim Group LLC following a strengthened financial position, including over $15 million received from warrant exercises in May 2026. The company is now debt-free with no exercisable warrants outstanding, providing sufficient cash runway to advance its autonomous…

Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month

Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month

Spectral AI, Inc., a US-based AI medical diagnostics company specializing in wound care, joins the American Board of Wound Management Foundation in celebrating Wound Healing Awareness Month. The company highlights its DeepView System for burn wounds, which recently gained FDA De Novo classification, enabling faster and more accurate treatment decis…

LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS)

LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS)

LIXTE Biotechnology Holdings, Inc. announced a definitive agreement to acquire NOMAD Transportable Power Systems, a leader in mobile, utility-grade 1 MW battery energy storage systems (BESS). Post-acquisition, LIXTE will rebrand as NOMAD Power Solutions, shifting focus to address the growing power capacity demand driven by AI, electrification, and …

Park Ha Biological Technology Co., Ltd. announces strategic partnership with Star Plus Legend Group’s wholly-owned subsidiary to build an AI-powered skincare and health ecosystem and expand its healthcare reach

Park Ha Biological Technology Co., Ltd. announces strategic partnership with Star Plus Legend Group’s wholly-owned subsidiary to build an AI-powered skincare and health ecosystem and expand its healthcare reach

Park Ha Biological Technology Co., Ltd., listed on NASDAQ as BYAH, has formed a strategic partnership with Star Plus Action, a subsidiary of Hong Kong-listed Star Plus Legend Holdings. The collaboration aims to merge AI technology, skincare product development, celebrity IP management, and health maintenance to innovate the beauty and wellness indu…

OFA Group Receives Additional 180-Day Nasdaq Compliance Period; Nasdaq Confirms Company Remains Compliant with All Continued Listing Standards Other Than the Minimum Bid Price Requirement

OFA Group Receives Additional 180-Day Nasdaq Compliance Period; Nasdaq Confirms Company Remains Compliant with All Continued Listing Standards Other Than the Minimum Bid Price Requirement

OFA Group (Nasdaq: OFAL) announced that Nasdaq has granted it a second 180-day extension, until December 7, 2026, to regain compliance with the minimum $1.00 bid price per share rule. The company remains compliant with all other Nasdaq Capital Market listing standards. OFA may implement a reverse stock split if necessary to meet the requirement. Tr…

KE Holdings Inc. Announces Results of Annual General Meeting

KE Holdings Inc. Announces Results of Annual General Meeting

KE Holdings Inc. reported that all resolutions presented at its 2026 Annual General Meeting were approved, including amendments to its memorandum and articles of association, the re-election of key directors, and granting of general mandates for share issuance and repurchase. The company remains focused on its integrated online and offline real est…

Cogent Biosciences Announces Preclinical Data from Novel JAK2 V617F Inhibitor at the 2026 European Hematology Association (EHA) Congress

Cogent Biosciences Announces Preclinical Data from Novel JAK2 V617F Inhibitor at the 2026 European Hematology Association (EHA) Congress

Cogent Biosciences announced encouraging preclinical results of CGT1145, a novel JAK2 V617F mutant-selective inhibitor, at the 2026 European Hematology Association Congress. The drug showed over 100-fold selectivity for the mutant over wild-type JAK2, with potential to treat myeloproliferative neoplasms while minimizing off-target effects. The comp…

Rezolve Ai Board Moves to Authorize Capital Reduction and Up to $300 Million Share Repurchase Program

Rezolve Ai Board Moves to Authorize Capital Reduction and Up to $300 Million Share Repurchase Program

Rezolve Ai's Board of Directors will seek shareholder approval to reduce capital and repurchase up to $300 million of ordinary shares through an agreement with BTIG. The program demonstrates confidence in the company's growth prospects and aims to address what the Board sees as market undervaluation. The repurchases will be funded from cash reserve…

Independent Bank Corporation Announces Regulatory Approvals to Acquire HCB Financial Corp. and Highpoint Community Bank

Independent Bank Corporation Announces Regulatory Approvals to Acquire HCB Financial Corp. and Highpoint Community Bank

Independent Bank Corporation (NASDAQ: IBCP) announced it has received regulatory approval from the Federal Reserve Bank of Chicago and the Michigan Department of Insurance and Financial Services to acquire HCB Financial Corp., the parent company of Highpoint Community Bank. The merger, pending HCB shareholder approval, is expected to close July 1, …

Profusa Submits Response Package to GMED as Part of Ongoing CE Mark Review Process for Lumee® Oxygen Platform

Profusa Submits Response Package to GMED as Part of Ongoing CE Mark Review Process for Lumee® Oxygen Platform

Profusa, Inc. announced the submission of its response to the European notified body GMED as part of the ongoing Medical Device Regulation (MDR) conformity assessment for its Lumee Oxygen Platform. This milestone advances the company's efforts to obtain CE Mark certification, critical for commercializing its real-time tissue oxygen monitoring biose…

UniFirst Shareholders Approve Transaction with Cintas

UniFirst Shareholders Approve Transaction with Cintas

UniFirst Corporation announced that more than 99% of shareholders approved its acquisition by Cintas Corporation. Under the agreement, UniFirst shareholders will receive $155 per share in cash plus 0.7720 shares of Cintas stock. The transaction is expected to close in the second half of 2026, pending customary conditions and regulatory approvals. T…

Kalaris to Present at Clinical Trials at the Summit 2026

Kalaris to Present at Clinical Trials at the Summit 2026

Kalaris Therapeutics announced the presentation of Phase 1a clinical trial data for its lead asset TH103, a novel dual-targeting biologic for neovascular Age-Related Macular Degeneration (nAMD), at Clinical Trials at the Summit 2026. The data demonstrates early safety and efficacy signals. TH103, designed by noted VEGF scientist Dr. Napoleone Ferra…

Cogent Biosciences Announces Detailed Data from APEX Pivotal Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis at the 2026 European Hematology Association (EHA) Congress

Cogent Biosciences Announces Detailed Data from APEX Pivotal Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis at the 2026 European Hematology Association (EHA) Congress

Cogent Biosciences reported detailed and updated clinical data from its pivotal APEX trial of bezuclastinib in patients with advanced systemic mastocytosis (AdvSM), demonstrating a high objective response rate, robust disease pathology improvements, and a favorable safety profile. The company plans an NDA submission in June 2026 and anticipates FDA…